The CD3 versus CD7 Plot in Multicolor Flow Cytometry Reflects Progression of Disease Stage in Patients Infected with HTLV-I

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kobayashi, Seiichiro ^a   Tian, Yamin ^a,b   Ohno, Nobuhiro ^a   Yuji, Koichiro ^a   Ishigaki, Tomohiro ^a   Isobe, Masamichi ^a   Tsuda, Mayuko ^a   Oyaizu, Naoki ^a   Watanabe, Eri ^a   Watanabe, Nobukazu ^a   Tani, Kenzaburo ^b   Tojo, Arinobu ^a   Uchimaru, Kaoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD7 ANTIGEN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; CELL CLONE; CHRONIC DISEASE; CLONAL VARIATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INDOLENT TYPE ADULT T CELL LEUKEMIA LYMPHOMA; INVERSE POLYMERASE CHAIN REACTION; MAJOR CLINICAL STUDY; MALE; MULTICOLOR FLOW CYTOMETRY; PATIENT CODING; PERIPHERAL BLOOD MONONUCLEAR CELL; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD7; ASYMPTOMATIC INFECTIONS; COLOR; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RISK FACTORS; VIRAL LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84872776976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053728     Document Type: Article

References (29)

1. Yoshida M, Miyoshi I, Hinuma Y, (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79: 2031-2035.
2. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, et al. (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
3. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, et al. (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Japanese journal of cancer research: Gann 83: 236-239.
4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL, (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068.
5. Yamaguchi K, Watanabe T, (2002) Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. International journal of hematology 76 Suppl 2: 240-245.
6. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, et al. (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. International journal of cancer Journal international du cancer 43: 250-253.
7. Shimoyama M, (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79: 428-437.
8. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, et al. (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27: 453-459.
9. Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, et al. (2010) Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 115: 4337-4343.
10. Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, et al. (1998) Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 92: 3557-3561.
11. Imaizumi Y, Iwanaga M, Tsukasaki K, Hata T, Tomonaga M, et al. (2005) Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study. Blood 105: 903-904.
12. Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, et al. (1994) Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73: 2753-2758.
13. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, et al. (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116: 1211-1219.
14. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, et al. (1989) Multi-step carcinogenesis model for adult T-cell leukemia. Japanese journal of cancer research: Gann 80: 191-195.
15. Matsuoka M, Jeang KT, (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7: 270-280.
16. Yoshida M, (2010) Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia. Proceedings of the Japan Academy Series B, Physical and biological sciences 86: 117-130.
17. Tian Y, Kobayashi S, Ohno N, Isobe M, Tsuda M, et al. (2011) Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer science 102: 569-577.
18. Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, et al. (1984) Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. International journal of cancer Journal international du cancer 34: 221-228.
19. Yamaguchi K, Kiyokawa T, Nakada K, Yul LS, Asou N, et al. (1988) Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. British journal of haematology 68: 169-174.
20. Mortreux F, Gabet AS, Wattel E, (2003) Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 17: 26-38.
21. Sasaki D, Doi Y, Hasegawa H, Yanagihara K, Tsukasaki K, et al. (2010) High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders. Virology journal 7: 81.
22. Setoyama M, Katahira Y, Kanzaki T, (1999) Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought. The Journal of dermatology 26: 785-790.
23. Reinhold U, Abken H, (1997) CD4+ CD7- T cells: a separate subpopulation of memory T cells? J Clin Immunol 17: 265-271.
24. Reinhold U, Abken H, Kukel S, Moll M, Muller R, et al. (1993) CD7- T cells represent a subset of normal human blood lymphocytes. J Immunol 150: 2081-2089.
25. Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, et al. (2004) Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 104: 3672-3678.
26. Autran B, Legac E, Blanc C, Debre P, (1995) A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J Immunol 154: 1408-1417.
27. Legac E, Autran B, Merle-Beral H, Katlama C, Debre P, (1992) CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 79: 1746-1753.
28. Schmidt D, Goronzy JJ, Weyand CM, (1996) CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97: 2027-2037.
29. Willard-Gallo KE, Van de Keere F, Kettmann R, (1990) A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci U S A 87: 6713-6717.